Bioinductive Patch for Full-Thickness Rotator Cuff Tears
Arthroscopic Rotator Cuff Repair Augmented With Bioinductive Implant for Full-Thickness Tears: A Randomized Controlled Study
1 other identifier
interventional
78
1 country
1
Brief Summary
The purpose of this randomized-controlled study is to compare outcomes of arthroscopic rotator cuff repair augmented with a Bioinductive Implant (study group) to standard arthroscopic rotator cuff repair (control group). The primary outcome of this study is rotator cuff repair integrity (absence of full- or partial-thickness defect) demonstrated on ultrasound at 1-year postoperatively. The investigators hypothesize that the study group will have higher rates of repair integrity demonstrated on ultrasound at 1-year postoperatively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Aug 2022
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2022
CompletedFirst Posted
Study publicly available on registry
June 30, 2022
CompletedStudy Start
First participant enrolled
August 16, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2029
February 27, 2026
February 1, 2026
5.9 years
June 18, 2022
February 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rotator cuff repair integrity
absence of full- or partial-thickness defect as demonstrated on ultrasound at 1-year postoperatively.
Preoperative to 1 year postoperative
Secondary Outcomes (7)
PROMs scores for upper extremity function
Preoperative to 2 years postoperative
PROMs scores for depression
Preoperative to 2 years postoperative
PROMs scores for upper extremity pain interference
Preoperative to 2 years postoperative
Shoulder Range of Motion
Preoperative to 2 years postoperative
Shoulder Strength
Preoperative to 2 years postoperative
- +2 more secondary outcomes
Study Arms (2)
Control Group
ACTIVE COMPARATORSurgical treatment alone, consisting of arthroscopic rotator cuff repair. Ultrasound postoperatively at 1 year.
Study Group
EXPERIMENTALIdentical surgical treatment as control group plus bio-inductive patch implant. Ultrasound postoperatively at 1 year.
Interventions
This procedure is the standard of care for rotator cuff tears who fail conservative treatment options.
A bioinductive implant that is designed to promote healing of the torn rotator cuff tendon after surgery.
An ultrasound will be performed on each patient one year postoperatively.
Eligibility Criteria
You may qualify if:
- Indicated and scheduled for arthroscopic rotator cuff repair.
- Full-thickness medium (1-3 cm), large (3-5 cm), and massive (\>5 cm) rotator cuff tears involving the supraspinatus and/or infraspinatus tendons demonstrated on magnetic resonance or ultrasound imaging.
- Chronic, degenerative rotator cuff tears.
- Ability to read and understand English.
- Age ≥18 years
- Patient failed ≥6 weeks of conservative treatment, which included structured, in-person physical therapy or documented home therapy
You may not qualify if:
- Patient scheduled for open or mini-open rotator cuff repair
- Prior surgery of affected shoulder (except diagnostic arthroscopy)
- Partial-thickness rotator cuff tears
- Small (\<1 cm) rotator cuff tears
- Rotator cuff tears involving the subscapularis tendon
- Acute and traumatic rotator cuff tears
- Active infection
- Cancer
- Autoimmune and rheumatologic disorders, including rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Henry Ford Health
Detroit, Michigan, 48202, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephanie J Muh, MC
Henry Ford Health
Central Study Contacts
Stephanie J Muh, MD
CONTACT
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The study participant will not have knowledge of which treatment group he/she is randomized into for the duration of the study. Because the care provider/investigator will be required to implant the bioinductive patch, the physician will know into which treatment group each patient falls.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy Service Chief, Principal Investigator
Study Record Dates
First Submitted
June 18, 2022
First Posted
June 30, 2022
Study Start
August 16, 2022
Primary Completion (Estimated)
July 1, 2028
Study Completion (Estimated)
July 1, 2029
Last Updated
February 27, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
No IPD will be shared with other researchers.